Assertio Therapeutics (NASDAQ:ASRT) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 175 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $34.21 million which beat the analyst consensus estimate of $31.33 million by 9.20 percent. This is a 34.31 percent increase over sales of $25.47 million the same period last year.
Stifel Maintains Buy on Capital Product Partners, Lowers Price Target to $17
Stifel analyst Benjamin Nolan maintains Capital Product Partners (NASDAQ:CPLP) with a Buy and lowers the price target from $20 to $17.
